Stephen Mandel - Lone Pine Capital
Holding/activity history for Fate Therapeutics Inc. (FATE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.44 | |
| 2021 Q3 | 2,199,284 | 0.44 | Add 25.72% | 0.09 | $59.27 |
| 2021 Q2 | 1,749,284 | 0.49 | $86.79 | ||
| 2021 Q1 | 1,749,284 | 0.52 | Add 97.96% | 0.26 | $82.45 |
| 2020 Q4 | 883,666 | 0.29 | Buy | 0.29 | $90.93 |